Benzinga | Feb 24, 2021 04:42PM EST

Global Blood Therapeutics Q4 EPS $(1.00) Misses $(0.94) Estimate, Sales $41.30M Beat $39.03M Estimate

Global Blood Therapeutics (NASDAQ:GBT) reported quarterly losses of $(1.00) per share which missed the analyst consensus estimate of $(0.94) by 6.38 percent. This is a 37.11 percent increase over losses of $(1.59) per share from the same period last year. The company reported quarterly sales of $41.30 million which beat the analyst consensus estimate of $39.03 million by 5.80 percent. This is a 1.86K percent increase over sales of $2.11 million the same period last year.